German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent pipeline setbacks but raised its electronics forecast, citing strong ...

Merck KGaA cut its mid-term sales growth target for its health-care division after a number of high-profile drug trial ...

British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of ...

the Instituto de Salud Carlos III, the Merck Foundation and the International Josep Carreras Foundation. No generative AI tools have been used in the production of this manuscript.

The major U.S. index futures are currently pointing to a lower open on Thursday, with stocks likely to give back ground following the ...

Arcus Biosciences (RCUS) has received a new Buy rating, initiated by Wells Fargo analyst, Eva Fortea Verdejo. Eva Fortea Verdejo’s rating ...

Your Account Isn't Verified! In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.

According to the Merck Veterinary Manual ... talk to your veterinarian. You can purchase logo and accolade licensing to this story here. Disclosure: Written and researched by the Insider Reviews ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...